Literature DB >> 25040382

Is it reasonable to deny older patients treatment for glioblastoma?

Michael K Gusmano1.   

Abstract

Is it ever fair to limit treatment for diseases like glioblastoma for which prognosis is poor? Because resources are finite and health care spending limits the other possible uses for those resources, limiting access to an intervention that does not generate benefits is ethically sound. Ignoring the balance of benefits and burdens associated with treatment ignores opportunity costs and leads us to treat some lives as more valuable than others. Although it is ethically sound to set limits on medical care, I argue that biological age is a poor criterion for allocating resources.
© 2014 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25040382     DOI: 10.1111/jlme.12134

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  1 in total

1.  Introduction: Brain science in the 21st century: clinical controversies and ethical and legal implications.

Authors:  Robert M Sade
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.